Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anosmia and / or Ageusia in COVID-19: Timeline, Treatment With Early Corticosteroid and Recovery

NCT04528329 is registered in ClinicalTrials.gov with ClinAmygate as lead sponsor.

NCT NCT04528329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04528329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anosmia and / or Ageusia in COVID-19: Timeline, Treatment With Early Corticosteroid and Recovery
Lead sponsor
ClinAmygate
Phase
Phase 4
Overall status
Unknown status
Start date
March 30, 2021
Completion date
December 30, 2023
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anosmia, covid19